NEET 2024 Controversy: Can’t Hold Re-test for Solitary Candidate, says SC on aspirant’s plea

New Delhi: While considering a plea alleging the involvement of the National Testing Agency (NTA) officers in the manipulation of the OMR sheets of the NEET-UG exam, the Supreme Court today i.e. on July 1st clarified that a re-test cannot be held for a solitary person. 

“Are you thinking that for you, a solitary person, a re-test will be conducted? Please do not hope against hope,” the top court vacation bench of Justices C.T Ravikumar and Manoj Misra told the counsel appearing for the petitioner.

Adjourning the plea, the Apex Court has listed it for a further hearing on 8th July, 2024.

The petitioner submitted that he appeared in the National Eligibility-and-Entrance Test Undergraduate (NEET-UG) 2024 examination on May 5th, 2024 and allegedly his OMR was swapped. Based on that, he had urged the court to allow him to appear in the NEET-UG 2024 re-test held on June 23, 2024. 

Medical Dialogues had earlier reported that NTA held a re-test for 1563 candidates, who were earlier awarded grace marks to compensate for their loss of time during the exam. The Union Government and NTA decided to withdraw the grace marks after the issue was challenged before the Supreme Court.

Also Read: NEET 2024 Paper Leak Case: SC Stays Proceedings in 3 High Courts

As per the latest media report by Live Law, the Apex Court vacation bench questioned the petitioner’s counsel for approaching the Court under Article 32 of the Constitution of India. Responding to this, the counsel submitted, “I am a topper of these exams. Respondents had the audacity to swap my OMR, and the same two petitions were filed before the High Court.

However, considering the fact that the petitioner was asking for a re-test and the re-neet for 1563 candidates was conducted on June 23rd, the Apex Court bench observed, “The examination in which you want an order in your favour to allow you to appear, that was already over on 23.06.2024.”

Responding to this, the counsel stated that the relief measure may be granted in case a re-test is ordered by the Top Court.

Earlier, the top court had adjourned the plea to this week after asking the petitioner to withdraw a similar plea filed before the High Court. Previously, the petitioner had also requested a week’s time to file an affidavit explaining the pendency of a similar plea before the High Court. However, during the hearing of the case on July 1st, the counsel for the petitioner requested the Court to grant two days to place on record this affidavit. 

Ultimately, the Court adjourned the matter to two weeks and observed that it would not observe anything in the plea. Listing the matter for further hearing on July 8, the Court observed, “Sometimes, if you are fortunate, some order will be there in the other matter. We do not know if that will re-resurrect your claim. It depends. On this matter, we will not say anything.”

Although the counsel persisted in listing the matter on July 09, however, Justice Ravikumar refused to do so and observed, “Are you thinking that for you, a solitary person, a re-test will be conducted? Please do not hope against hope.”

This year’s NEET UG 2024 exam was mired in controversies after a paper leak scam came to light. Medical Dialogues had earlier reported that around 13 people, including four examinees and their family members, were arrested in Bihar for their alleged involvement in the paper leak of the NEET-UG exam. Patna police sources had previously claimed that the NEET-UG question papers along with their answers were provided to around 20 aspirants a day before the date of the exam i.e. May 5, 2024.

Then, the Economic Offences Unit (EOU) of Bihar Police, which took over the investigation, revealed that the brokers involved in the NEET paper leak scam took between Rs 30 lakh to Rs 50 lakh from each of the medical aspirants in exchange for giving them the question paper of the NEET UG 2024 question paper ahead of the examination.

Multiple pleas have been filed before the High Courts and the Supreme Court seeking an investigation into the alleged paper leak scam. Some of the pleas demanded the scrapping of the NEET UG 2024 exam and holding a retest. Meanwhile, during the case proceedings, NTA earlier decided to withdraw the grace marks awarded to 1563 candidates and hold an optional retest for those candidates. Those who did not opt for the retest were allowed to retain their original marks, without the grace marks.

The matter is now being investigated by the Central Bureau of Investigation (CBI). Central Government on June 22, 2024, handed over the charge of investigating in the alleged irregularities in the NEET UG 2024 examination to the Central Bureau of Investigation (CBI).

“Certain cases of alleged irregularities / cheating / impersonation / malpractices have been reported. For transparency on the conduct of the examination process, the Ministry of Education, Government of India after a review has decided to entrust the matter to the Central Bureau of Investigation (CBI) for a comprehensive investigation,” the Ministry of Education stated in a release.

Earlier, while considering the NEET-related pleas, the Supreme Court had refused to defer the counselling/seat allotment process scheduled to commence on July 6. However, the bench had orally observed that the admissions would be subject to the final outcome of the petitions and if the exams were set aside, the counselling would get invalidated consequentially.

The Top Court had also expressed its concern over the alleged discrepancies in the NEET UG 2024 exam. The Court had noted that even ‘0.001& negligence’ in conducting the NEET-UG 2024 exams would be looked into with all seriousness considering the immense labor put in by the candidates for the prestigious examination.

Also Read: NEET 2024 Results Row: Supreme Court pulls up NTA, says ‘Even 0.001 percent negligence Should be Thoroughly Dealt With’

Powered by WPeMatico

Sipavibart EMA regulatory submission accepted under accelerated assessment for COVID 19 prevention: AsraZeneca

Cambridge: AstraZeneca’s Marketing Authorisation Application (MAA) for sipavibart has been accepted under an accelerated assessment procedure by the European Medicines Agency (EMA), for the pre-exposure prophylaxis (prevention) of COVID-19 in immunocompromised patients.

Sipavibart is an investigational long-acting antibody designed to provide COVID-19 protection for immunocompromised patients who often do not respond adequately to vaccination alone and remain at high risk of serious outcomes from COVID-19.

The EMA’s Committee for Medicinal Products for Human Use (CHMP) granted sipavibart accelerated assessment as it was deemed of major interest for public health and therapeutic innovation. Accelerated assessment aims to reduce the timeframe for the CHMP to review a MAA compared to the standard procedure.

The MAA is based on positive results from the SUPERNOVA Phase III trial which demonstrated sipavibart’s safety and efficacy in preventing symptomatic COVID-19 in immunocompromised patients, compared to control, in a variant landscape in which COVID-19 cases captured over the course of the trial were caused by several different SARS-CoV-2 variants. SUPERNOVA is the only Phase III trial that provides efficacy data for COVID-19 pre-exposure prophylaxis exclusively in immunocompromised patients.

Prof. Paul Loubet, M.D., Ph.D., MPH, Professor of infectious diseases, University of Montpellier, head of the Infectious and Tropical Diseases department, Nîmes University Hospital, France, and SUPERNOVA trial investigator, said, “The disease burden of COVID-19 remains high for immunocompromised patients who are disproportionately impacted compared to the general population, despite vaccination. With cases expected to rise in the winter months, adding more pressure to stretched healthcare systems, sipavibart has the potential to be an important option for immunocompromised patients who remain at risk, and it has demonstrated COVID-19 protection in a mixed variant environment.”

Iskra Reic, Executive Vice President, Vaccines and Immune Therapies, AstraZeneca, said, “Immunocompromised patients currently have no options for COVID-19 protection in Europe beyond vaccination, which often is not sufficient to protect them against serious COVID-19 outcomes. We are pleased that the EMA has accepted this regulatory submission with an accelerated assessment procedure and will work to bring sipavibart to these highly vulnerable patients.”

Data from the SUPERNOVA trial will be presented at a forthcoming medical meeting.

In addition to the EMA, AstraZeneca is in dialogue with other regulatory authorities on potential authorisation or approval pathways for sipavibart.

Sipavibart (formerly AZD3152) is an investigational long-acting monoclonal antibody (LAAB) against COVID-19. Sipavibart was designed to provide broad and potent coverage across Omicron and ancestral viral variants by neutralising spike protein interaction with the host receptor ACE2.

Sipavibart was derived from B-cells donated by convalescent patients after SARS-CoV-2 infection. Sipavibart has been engineered using the same antibody scaffold as Evusheld and was optimised with the same half-life extension and reduced Fc effector function and complement C1q binding platform. The reduced Fc effector function aims to minimise the risk of antibody-dependent enhancement of disease – a phenomenon in which virus-specific antibodies promote, rather than inhibit, infection and/or disease.

Sipavibart was licensed by AstraZeneca in May 2022 from RQ Biotechnology.

Read also: AstraZeneca Truqap, Faslodex combo approved in EU for advanced ER-positive breast cancer

Powered by WPeMatico

Alleged Delay in Treatment: Pregnant woman dies at Delhi Govt Hospital, Probe on

New Delhi: The medical staff at a government-run Pandit Madan Mohan Malviya Hospital in Malviya Nagar are facing accusations of medical negligence following the tragic death of a 38-week pregnant woman and her unborn child on Saturday.    

According to reports, Singh the husband of the deceased alleged that the hospital staff failed to provide her with adequate treatment. He further claimed that no senior doctors attended her when she was experiencing complications at the hospital.   

The incident happened on Saturday, June 29, at the government-run Pandit Madan Mohan Malviya Hospital in Malviya Nagar where a 23-year-old pregnant woman was admitted in critical condition.  

As per Singh’s statements, the patient was asked to undergo an ultrasound which later revealed that the breast condition was indicated as ‘urgent’. After reviewing the report, a doctor administered pain medication and an injection in the emergency room. The patient was instructed to rest for thirty minutes before being discharged. Later, another doctor ordered an ECG. Following these events, both the woman and her unborn child were pronounced dead by the doctors around 1.30 pm.

Also read- BAMS Doctor Performs Delivery At Patiala Nursing Home, Patient Dies Of Postpartum Haemorrhage

Alleging that his wife waited for nearly three hours and did not receive timely care from senior doctors, he expressed his grief and disappointment with the hospital’s handling of his wife’s case. He alleged that the medical staff failed to provide adequate care and attention to his wife during her critical condition.  

Following this, he approached the police and filed a complaint against the hospital staff. When the police arrived, they sent her body for postmortem to determine the cause of her death. Police said, “In such cases, we rely on postmortem reports and take opinion from Delhi Medical Council.”

Speaking to TOI, Singh said, “My wife’s body has been sent to a mortuary for postmortem.” A family member of the deceased said, “Her remains were being transported to All India Institute of Medical Sciences for an autopsy on Sunday. 

Meanwhile, Dr Pankaj Agarwal, the media nodal officer of the hospital said, “Based on preliminary details, the patient, who was 38 weeks pregnant, was under the care of a senior gynaecologist. Until the postmortem happens, we cannot comment on details.”

“The patient’s body had been handed over to police. An autopsy will be conducted to know the cause of death. The medical examiner will perform a thorough postmortem examination to determine the factors that led to the patient’s demise. Further investigations may be conducted based on the findings of the autopsy,” Dr Agarwal added. 

Also read- 35-Year-Old Patient Dies During Treatment At Thiruvananthapuram Hospital, Kin Alleges Medical Negligence

Powered by WPeMatico

CDSCO Panel Approves AstraZeneca pharma’s Protocol Amendment proposal to study Anifrolumab

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major AstraZeneca Pharma India’s protocol amendment proposal to study anifrolumab.

This came after the firm presented protocol amendment version 3.0 dated 07. 3. 2024 protocol no. D3460C00002. The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus placebo in adult participants with systemic sclerosis.

Anifrolumab is a monoclonal antibody that inhibits type 1 interferon receptors and is indicated for treating moderate to severe systemic lupus erythematosus. This binding inhibits type I IFN signaling, thereby blocking the biological activity of type I IFNs. Anifrolumab-final also induces the internalization of IFNAR1, thereby reducing the levels of cell surface IFNAR1 available for receptor assembly.

Systemic sclerosis, or scleroderma, is a rare connective tissue disorder with an unknown and complex pathogenesis. The pathophysiology of systemic sclerosis is intricate and not entirely understood. The disease is characterized by 3 main hallmarks: vascular insult, autoimmunity, and tissue fibrosis.

At the recent SEC meeting for analgesics and rheumatology held on June 12 and 13, 2024, the expert panel reviewed protocol amendment version 3.0 dated 07. 3. 2024 protocol no. D3460C00002.

After detailed deliberation, the committee recommended the approval of the protocol amendment as presented by the firm.

Also Read: Sun Pharma Laboratories Gets CDSCO Panel Nod To study Antidiabetic FDC Drug

Powered by WPeMatico

Max Hospital, doctor ordered to pay Rs 8 lakh compensation for misdiagnosing COVID, improper treatment

The State Consumer Disputes Redressal Commission (SCDRC), Mohali recently directed Max Super Speciality Hospital and one of its doctors to pay Rs 8 lakh to a man for medical negligence during the treatment of his elderly mother back in 2020.

As per the complainant, the patient and her family had to suffer because of the wrong COVID-positive report given by the hospital. Earlier, the District Commission had directed the hospital and its Head of Microbiology department to pay Rs 5 lakh compensation. However, the State Commission increased the amount of compensation to Rs 8 lakh.

For more information, click on the link below:

Max Hospital, Head Microbiology Slapped Rs 8 Lakh Compensation For Misdiagnosing COVID-19, Improper Treatment


Powered by WPeMatico

NTA declares NEET 2024 re-exam results

The National Testing Agency (NTA) has declared the results of the National Eligibility- Entrance Test, Undergraduate (NEET UG) 2024 re-exam. This re-exam was conducted for 1,563 candidates who had experienced a loss of time during the originally scheduled examination on 05th May 2024 and were still awarded the compensatory marks. The candidates can check their scores on the official website of NTA

On this, NTA has released a notice, stating that “It is now informed that revised Score Cards of all Candidates of NEET (UG) 2024 (including of 1563 Candidates who appeared in the Re-Test on 23 June 2024), are being hosted on the website. Candidates can log in to the website and view/download/print their respective revised Score Cards”.

For more information, click on the link below:

NEET 2024 Re-Exam Results OUT


Powered by WPeMatico

NEET paper leak update: CBI arrests private school owner in Godhra for allegedly taking Rs 10 lakh from at least 27 candidates each

Godhra: In the latest update regarding the alleged malpractices in the NEET UG 2024 exam, the Central Bureau of Investigation probing the case has arrested the owner of a private school in Godhra of Gujarat recently for allegedly accepting Rs 10 lakh from at least 27 candidates each to assist them in passing the exam.

With the arrest of Patel, owner of Jay Jalaram School situated near Godhra in Panchmahal district, the number of persons arrested so far- five held by Gujarat Police- has increased to six.

Jay Jalaram School was one of the designated centres where the NEET-UG exam was held on May 5.

Patel was arrested in the early hours of Sunday from his residence in Panchmahal district, said public prosecutor Rakesh Thakor.

“As the case has been handed over to the CBI by the Gujarat government, a CBI team will produce him (Dixit Patel) before a designated court in Ahmedabad to acquire his remand,” said Thakor informed PTI. 

Also read- NEET Case Updates: CBI Conducts Searches At 7 Locations In Gujarat

Patel is the sixth person to be arrested in this case wherein the accused had allegedly demanded Rs 10 lakh each from at least 27 candidates to help them clear the test.

The other five persons, who were arrested earlier by the Panchmahal police, include Vadodara-based education consultant Parshuram Roy, Jay Jalaram School principal Purushottam Sharma, school teacher Tushar Bhatt, and alleged middlemen Vibhor Anand and Arif Vohra.

After taking over the probe a week back, the CBI had sought custody of four accused except Roy. On Saturday, the Godhra district court remanded Sharma, Bhatt, Anand, and Vohra to CBI’s custody till July 2.

A preliminary investigation by the CBI has uncovered that the accused persons had asked candidates willing to adopt illegal means to obtain high scores in the National Eligibility-and-Entrance Test (NEET-Under Graduate) to opt for Jay Jalaram School as the exam centre.

Last year’s NEET exam at the same school had exposed a crucial vulnerability wherein answer sheets were stored overnight, prompting the accused to conceive a plan to tamper with Optical Mark Recognition (OMR) sheets during this period, the CBI had told the court.

As per Gujarat Police, the accused persons allegedly asked the candidates not to attempt a question if they did not know the answer.

Prima facie, Bhatt, a physics teacher, filled in the correct answers on the papers while they were still at the school premises post-exam.

The CBI on Saturday raided seven locations in Gujarat, further intensifying their probe into the alleged NEET malpractices. Statements from six candidates who allegedly paid bribes were recorded last week, linking them to the accused.

A case was registered by Godhra Police on May 8 against Bhatt, Roy, and Vohra for attempting to manipulate the NEET-UG process by extorting Rs 10 lakh from 27 candidates each. Authorities, who were tipped off about potential malpractice, preemptively intervened at the school, averting irregularities.

Bhatt, appointed as the exam’s deputy superintendent at the school centre, was apprehended before the test, and Rs 7 lakh in cash was seized from him.

The investigation showed that Roy had allegedly convinced at least 27 of his students that he could help them clear the exam for Rs 10 lakh. In a subsequent raid, cheques amounting to Rs 2.30 crore were discovered in Roy’s office.

Roy had allegedly asked his students to opt for the Godhra centre so that Bhatt, Sharma and others could help them.

Of the 27 students who had either paid in advance or agreed to pay money to Roy and others, only three managed to clear the exam with a passing score, while the remaining 23 failed. Investigations continue as the CBI seeks to unravel the full extent of the malpractice network.

This year’s NEET UG 2024 exam was mired in controversies after a paper leak scam came to the light. Medical Dialogues had earlier reported that around 13 people, including four examinees and their family members, were arrested in Bihar for their alleged involvement in the paper leak of the NEET-UG exam. Patna police sources had previously claimed that the NEET-UG question papers along with their answers were provided to around 20 aspirants a day before the date of the exam i.e. May 5, 2024.

Then, the Economic Offences Unit (EOU) of Bihar Police, which took over the investigation, revealed that the brokers involved in the NEET paper leak scam took between Rs 30 lakh to Rs 50 lakh from each of the medical aspirants in exchange for giving them the question paper of the NEET UG 2024 question paper ahead of the examination.

Multiple pleas have been filed before the High Courts and the Supreme Court seeking an investigation into the alleged paper leak scam. Some of the pleas demanded the scrapping of the NEET UG 2024 exam and holding a retest. Meanwhile, during the case proceedings, NTA earlier decided to withdraw the grace marks awarded to 1563 candidates and hold an optional retest for those candidates. Those who did not opt for the retest were allowed to retain their original marks, without the grace marks.

The matter is now being investigated by the Central Bureau of Investigation (CBI). Central Government on June 22, 2024, handed over the charge of investigation in the alleged irregularities in the NEET UG 2024 examination to the Central Bureau of Investigation (CBI).

“Certain cases of alleged irregularities / cheating / impersonation / malpractices have been reported. For transparency on the conduct of the examination process, the Ministry of Education, Government of India after a review has decided to entrust the matter to the Central Bureau of Investigation (CBI) for comprehensive investigation,” the Ministry of Education stated in a release.

Also read- NEET Paper Leak Case: Delhi, Mumbai Crime Branches Arrest 10 Medical Students Of Jhalawar Medical College From Rajasthan For Interrogation

Powered by WPeMatico

South Korea’s Medical Reform Plan: Medical Professors to launch indefinite walkout from July 12

Seoul: A group of medical professors at three South Korea University-affiliated hospitals has announced plans to launch an indefinite voluntary walkout later this month. The move, scheduled to begin on July 12, will exclude the operation of emergency rooms and intensive care units.

This action comes amidst a prolonged standoff between doctors and the government regarding its medical reform plan. Despite facing significant resistance from doctors, the government approved a quota increase of approximately 1,500 students for medical schools in May to tackle the shortage of doctors. 

The emergency committee of the professors serving as senior doctors at the university announced the walkout starting July 12, excluding the operation of emergency rooms and intensive care units, calling for the government to “withdraw its pressure on medical students and trainee doctors” and engage in dialogue, Yonhap news agency reported.

According to the IANS report, “The medical community sought to launch a dialogue by offering solutions and compromises, but the government has flatly ignored all and abused its administrative orders,” the committee said in a statement.

Also Read:Medical School Quota Hike: South Korea pledges firm response to illegal acts ahead of Doctors’ collective action

The announcement came after professors at Severance Hospital, Gangnam Severance Hospital and Yongin Severance Hospital also began suspending the treatment of outpatients, non-emergency surgeries, and other services from Thursday last week.

Senior doctors at Asan Medical Center are also anticipated to launch a one-week walkout starting Thursday.

Despite strong opposition from doctors, the government finalised an admissions quota hike of some 1,500 students for medical schools in May to address the shortage of doctors.

Last month, the government asked hospitals to swiftly accept the resignations of trainee doctors who have left their worksites in protest of the government’s medical reform, in an apparent move to appease the junior doctors.

About 12,000 trainee doctors have left their jobs since late February to protest against a hike in the number of medical students. In a punitive step, the government ordered hospitals not to accept the resignations of trainee doctors to prevent them from seeking jobs at other clinics.

Last week, a committee formed by the medical community to navigate joint responses to its monthslong standoff with the government over the medical reform plan, decided to convene a nationwide debate on July 26 regarding the government’s medical reform, news agency IANS reported.

Powered by WPeMatico

Alzheimer’s risk higher if your mother had cognitive problems

The genetic risk of developing Alzheimer’s disease is more strongly influenced by the mother’s side than the father’s side, a recent study has discovered.

Powered by WPeMatico

If you’re pregnant, how accurate is your ‘due date’?

More than 1,700 pregnant women in South Australia have reportedly been given the wrong “due date” due to a technical error in their computerized medical records. This has prompted concerns some women may have had an early induction of labor as a result.

Powered by WPeMatico